重型再生障碍性贫血异基因造血干细胞移植后EBV病毒感染的临床特点分析(2)
參考文献
Landgren O， Gilbert ES， Rizzo JD， et al. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation[J]. Blood， 2009，113(20)：4992-5001.
llio F’Primon v，Tamiazzo S，et a1.Epstein-Barr vires reactivation in allogeneic stem cell transplantation is highly related to cytomegalovims reactivation[J]. Clin Transplant，2013，27(4)：E49l-E497.
van Esser JW，van der Holt B，Meijer E，et a1.Epstein-Barr vires(EBV)reactivation is a frequent event after allogeneic stem cell transplantation(SCT)and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT lJ j.Blood，2001.98(4)：972-978.
Hatton O，Martinez OM，Esquivel CO.Emerging therapeutic strategies for Epstein-Barr virus post-transplant lymphoproliferative disorder[J].Pediatr Transplant，2012，16(3)：220-229.
Rasche L，Kapp M，Einsele H，et al. EBV-induced posttransplant lymphoproliferative disorders： a persisting challenge in allogeneic hematopoetic SCT[J]. Bone Marrow Transplant， 2014，49(2)：163-167.
Funch DP，Walker AM，Schneider G，et a1.Ganciclovir andacyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients[J].Am J Transplant，2005，5(12)：2894-2900., http://www.100md.com(何合胜 齐晶 黄东平)
Landgren O， Gilbert ES， Rizzo JD， et al. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation[J]. Blood， 2009，113(20)：4992-5001.
llio F’Primon v，Tamiazzo S，et a1.Epstein-Barr vires reactivation in allogeneic stem cell transplantation is highly related to cytomegalovims reactivation[J]. Clin Transplant，2013，27(4)：E49l-E497.
van Esser JW，van der Holt B，Meijer E，et a1.Epstein-Barr vires(EBV)reactivation is a frequent event after allogeneic stem cell transplantation(SCT)and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT lJ j.Blood，2001.98(4)：972-978.
Hatton O，Martinez OM，Esquivel CO.Emerging therapeutic strategies for Epstein-Barr virus post-transplant lymphoproliferative disorder[J].Pediatr Transplant，2012，16(3)：220-229.
Rasche L，Kapp M，Einsele H，et al. EBV-induced posttransplant lymphoproliferative disorders： a persisting challenge in allogeneic hematopoetic SCT[J]. Bone Marrow Transplant， 2014，49(2)：163-167.
Funch DP，Walker AM，Schneider G，et a1.Ganciclovir andacyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients[J].Am J Transplant，2005，5(12)：2894-2900., http://www.100md.com(何合胜 齐晶 黄东平)